17:I[66739,["/_next/static/chunks/0.3dg.jzl0xwf.js?dpl=dpl_AKCjjFSX5DBQtwrUxMDn9jBjYq4C","/_next/static/chunks/05hx6kuf6-oy4.js?dpl=dpl_AKCjjFSX5DBQtwrUxMDn9jBjYq4C","/_next/static/chunks/0~heydqc5smtk.js?dpl=dpl_AKCjjFSX5DBQtwrUxMDn9jBjYq4C","/_next/static/chunks/0juapqyy99ga..js?dpl=dpl_AKCjjFSX5DBQtwrUxMDn9jBjYq4C","/_next/static/chunks/0n1.gwovf1vi..js?dpl=dpl_AKCjjFSX5DBQtwrUxMDn9jBjYq4C","/_next/static/chunks/06dn~uer6.43l.js?dpl=dpl_AKCjjFSX5DBQtwrUxMDn9jBjYq4C"],"default"] 19:I[38632,["/_next/static/chunks/0qqtp3r0h7kah.js?dpl=dpl_AKCjjFSX5DBQtwrUxMDn9jBjYq4C","/_next/static/chunks/0iukvycbd42rl.js?dpl=dpl_AKCjjFSX5DBQtwrUxMDn9jBjYq4C"],"IconMark"] 18:T4f0,

Catalyst Pharmaceuticals (CPRX) CEO Rich Daly on the company's strong 1Q, growth drivers, and its cash-rich position in a challenging market. Daly discusses the company's pipeline, including plans to expand its product for Lambert-Eaton Myasthenic Syndrome (LEMS) into the oncology space and potential M&A opportunities in the rare disease space.

======== Schwab Network ========

Empowering every investor and trader, every market day.

Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe

Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185

Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7

Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch

Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore

Watch on DistroTV - https://www.distro.tv/live/schwab-network/

About Schwab Network - https://schwabnetwork.com/about

CPRX CEO Highlights Strong Q1 & Growth Prospects Despite Market Challenges

Schwab Network

CPRX CEO Highlights Strong Q1 & Growth Prospects Despite Market Challenges